Evaluation of DBT - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Dialectical Behavior Therapy; Drug Counseling; Opioid Dependence
Intervention: Behavior Therapy (Behavioral)
Phase: N/A
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s): Marsha Linehan, Ph.D., Principal Investigator, Affiliation: University of Washington
Summary
The purpose of this study is to compare a one year treatment program of Dialectical Behavior
Therapy (DBT) + suboxone for opiate addicted individuals meeting criteria for borderline
personality disorder (BPD) to a one year program of standard drug counseling (I/GDC) +
suboxone. Drug counseling consists of manualized individual sessions + group therapy. This
trial is being completed at two sites, at the University of Washington and at Duke
University. One hundred and seventy-two individuals (86 per condition) with opiate
dependence and meeting criteria for BPD will be enrolled in a one-year treatment and a
one-year follow-up assessment. Each site (University of Washington, Duke) will enroll 86
clients with both treatment conditions being conducted at each site. Assessments measuring
drug use, suicidal behaviors, retention and other treatment-related behaviors, general
psychopathology and functioning, and increases in behavioral skills will be given at four
month intervals for the entire two years.
Clinical Details
Official title: Evaluation of Dialectical Behavior Therapy (DBT)
Study design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Primary outcome: Drug use
Secondary outcome: Suicidal BehaviorDepression, anxiety, Axis I diagnostic remission
Eligibility
Minimum age: 18 Years.
Maximum age: 60 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 1. Meets SCID-I criteria for opiate dependence. 2. Meets IPDE and SCID criteria for
BPD (DSM-IV) 3. Over 18 years old 4. Resides within commuting distance of treatment 5.
Consents to outpatient treatment for drug addiction
Exclusion Criteria:
- 1. Bipolar, Schizophrenia, Schizophreniform, or Schizoaffective Disorders, Psychosis
NOS 2. IQ less than 70; life threatening anorexia; current and chronic absence of
shelter; impending jail/prison for more than three weeks (problems which by their
presence or severity preclude ability to attend or understand treatment and/or
requires priority treatment over SUD treatment) 3. Court order to treatment, court
order to treatment or to jail, or agency order to treatment or loss of child custody
(due to consequent inability to freely drop-out of treatment) 4. Is pregnant, plans to
become pregnant during treatment phase, or becomes pregnant before random assignment
to study condition 5. Is unable to tolerate suboxone induction phase 6. Is currently
stable on methadone 7. Current benzodiazapine use from which the participant is
unwilling to taper 8. Refuses: to discontinue current mental health or drug abuse
treatment or random assignment.
Locations and Contacts
Behavioral Research and Therapy Clinics, Seattle, Washington 98195 1525, United States
Additional Information
Starting date: June 2004
Last updated: May 6, 2008
|